Jim Simons Akero Therapeutics, Inc. Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 28,000 shares of AKRO stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,000
Previous 199,000
85.93%
Holding current value
$1.5 Million
Previous $8.06 Million
81.45%
% of portfolio
0.0%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding AKRO
# of Institutions
298Shares Held
92.4MCall Options Held
1.72MPut Options Held
901K-
Janus Henderson Group PLC London, X06.74MShares$362 Million0.19% of portfolio
-
General Atlantic LLC New York, NY5.73MShares$308 Million10.64% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$300 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$294 Million4.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.53MShares$243 Million0.0% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.49B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...